Bimzelx 160 mg/mL injection Images
Generic Name: bimekizumab
This medication has been identified as Bimzelx 160 mg/mL injection. It is supplied by UCB, Inc.
Bimzelx is used in the treatment of Plaque Psoriasis and belongs to the drug class interleukin inhibitors. Bimzelx 160 mg/mL injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Bimzelx
- Generic Name
- bimekizumab
- Strength
- 160 mg/mL injection
- Availability
- Prescription only
- Drug Class
- Interleukin inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- UCB, Inc.
- National Drug Code (NDC)
- 50474-0781
More about Bimzelx (bimekizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
